Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis
Background Data are conflicting regarding the possible effects of statins in patients with idiopathic pulmonary fibrosis (IPF). This post hoc analysis assessed the effects of statin therapy on disease-related outcomes in IPF. Methods Patients randomised to placebo (n=624) in three controlled trials...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2017
|
| In: |
Thorax
Year: 2016, Jahrgang: 72, Heft: 2, Pages: 148-153 |
| ISSN: | 1468-3296 |
| DOI: | 10.1136/thoraxjnl-2016-208819 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1136/thoraxjnl-2016-208819 Verlag, kostenfrei, Volltext: http://thorax.bmj.com/content/72/2/148 
|
| Verfasserangaben: | Michael Kreuter, Francesco Bonella, Toby M. Maher, Ulrich Costabel, Paolo Spagnolo, Derek Weycker, Klaus-Uwe Kirchgaessler, Martin Kolb |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1576087557 | ||
| 003 | DE-627 | ||
| 005 | 20230427042925.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180606r20172016xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/thoraxjnl-2016-208819 |2 doi | |
| 035 | |a (DE-627)1576087557 | ||
| 035 | |a (DE-576)506087557 | ||
| 035 | |a (DE-599)BSZ506087557 | ||
| 035 | |a (OCoLC)1341011033 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kreuter, Michael |d 1972- |e VerfasserIn |0 (DE-588)122645995 |0 (DE-627)082066795 |0 (DE-576)293362742 |4 aut | |
| 245 | 1 | 0 | |a Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis |c Michael Kreuter, Francesco Bonella, Toby M. Maher, Ulrich Costabel, Paolo Spagnolo, Derek Weycker, Klaus-Uwe Kirchgaessler, Martin Kolb |
| 264 | 1 | |c 2017 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published October 5, 2016 | ||
| 500 | |a Gesehen am 06.06.2018 | ||
| 520 | |a Background Data are conflicting regarding the possible effects of statins in patients with idiopathic pulmonary fibrosis (IPF). This post hoc analysis assessed the effects of statin therapy on disease-related outcomes in IPF. Methods Patients randomised to placebo (n=624) in three controlled trials of pirfenidone in IPF (CAPACITY 004 and 006, ASCEND) were categorised by baseline statin use. Outcomes assessed during the 1-year follow-up included disease progression, mortality, hospitalisation and composite outcomes of death or ≥10% absolute decline in FVC and death or ≥50 m decline in 6-minute walk distance (6MWD). Results At baseline, 276 (44%) patients were statin users versus 348 (56%) non-users. Baseline characteristics were similar between groups, except statin users were older and had higher prevalence of cardiovascular disease and risk factors. In multivariate analyses adjusting for differences in baseline characteristics, statin users had lower risks of death or 6MWD decline (HR 0.69; 95% CI 0.48 to 0.99, p=0.0465), all-cause hospitalisation (HR 0.58; 95% CI 0.35 to 0.94, p=0.0289), respiratory-related hospitalisation (HR 0.44; 95% CI 0.25 to 0.80, p=0.0063) and IPF-related mortality (HR 0.36; 95% CI 0.14 to 0.95, p=0.0393) versus non-users. Non-significant treatment effects favouring statin use were observed for disease progression (HR 0.75; 95% CI 0.52 to 1.07, p=0.1135), all-cause mortality (HR 0.54; 95% CI 0.24 to 1.21, p=0.1369) and death or FVC decline (HR 0.71; 95% CI 0.48 to 1.07, p=0.1032). Conclusions This post hoc analysis supports the hypothesis that statins may have a beneficial effect on clinical outcomes in IPF. Prospective clinical trials are required to validate these observations. Trial registration numbers NCT01366209, NCT00287729 and NCT00287716. | ||
| 534 | |c 2016 | ||
| 650 | 4 | |a Idiopathic pulmonary fibrosis | |
| 773 | 0 | 8 | |i Enthalten in |t Thorax |d London : BMJ Publishing Group, 1946 |g 72(2017), 2, Seite 148-153 |h Online-Ressource |w (DE-627)300184360 |w (DE-600)1481491-2 |w (DE-576)078941024 |x 1468-3296 |7 nnas |a Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis |
| 773 | 1 | 8 | |g volume:72 |g year:2017 |g number:2 |g pages:148-153 |g extent:6 |a Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/thoraxjnl-2016-208819 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://thorax.bmj.com/content/72/2/148 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180606 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 122645995 |a Kreuter, Michael |m 122645995:Kreuter, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PK122645995 |e 950000PK122645995 |e 950900PK122645995 |e 50000PK122645995 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1576087557 |e 3011738424 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1576087557","note":["First published October 5, 2016","Gesehen am 06.06.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis","title_sort":"Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis"}],"language":["eng"],"person":[{"roleDisplay":"VerfasserIn","role":"aut","given":"Michael","display":"Kreuter, Michael","family":"Kreuter"}],"relHost":[{"origin":[{"dateIssuedDisp":"1946-","publisher":"BMJ Publishing Group","dateIssuedKey":"1946","publisherPlace":"London"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"disp":"Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosisThorax","title":[{"title_sort":"Thorax","title":"Thorax","subtitle":"an international journal of respiratory medicine ; official journal of the British Thoracic Society"}],"id":{"issn":["1468-3296"],"eki":["300184360"],"zdb":["1481491-2"]},"titleAlt":[{"title":"eThorax"}],"corporate":[{"display":"Thoracic Society","role":"isb","roleDisplay":"Herausgebendes Organ"},{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"British Medical Association"}],"pubHistory":["1.1946 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 09.02.09","Beteil. Körp. anfangs: British Medical Association"],"part":{"volume":"72","issue":"2","text":"72(2017), 2, Seite 148-153","year":"2017","extent":"6","pages":"148-153"},"recId":"300184360"}],"origin":[{"dateIssuedDisp":"2017","dateIssuedKey":"2017"}],"name":{"displayForm":["Michael Kreuter, Francesco Bonella, Toby M. Maher, Ulrich Costabel, Paolo Spagnolo, Derek Weycker, Klaus-Uwe Kirchgaessler, Martin Kolb"]},"id":{"doi":["10.1136/thoraxjnl-2016-208819"],"eki":["1576087557"]},"physDesc":[{"extent":"6 S."}]} | ||
| SRT | |a KREUTERMICEFFECTOFST2017 | ||